MKPL

M K Proteins Limited

M K Proteins Limited (MKPL) financial statements and selected valuation metrics through 30 June 2026.

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Edible Oil

mkproteins.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹3.96
Market cap
149 Cr
Stock P/E
31.6
P/B
1.95
Dividend yield
0.0%
ROE (FY26)
9.0%
ROCE (FY26)
10.0%
Operating margin (FY26)
2.9%
Debt / equity (FY26)
0.47
OCF / EBITDA (3Y)
53.7%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

M K Proteins refines vegetable (edible) oil at its plant in Ambala, Haryana, and says this is its single business activity with no separate reportable segment.

Company snapshot

9thBy market cap

Ranked among 11 companies in Edible Oil.

What we see

Concerns
  • ✗Net margin is very thin at 1.8% — little room for error if costs rise.

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales14 Cr69 Cr87 Cr57 Cr34 Cr39 Cr137 Cr115 Cr32 Cr90 Cr146 Cr115 Cr
Operating expenses (approx.)13 Cr65 Cr78 Cr54 Cr31 Cr38 Cr133 Cr109 Cr31 Cr87 Cr143 Cr113 Cr
EBITDA0.64 Cr4 Cr8 Cr4 Cr2 Cr2 Cr5 Cr6 Cr1 Cr2 Cr2 Cr3 Cr
OPM %4.7%5.2%9.7%6.5%6.6%4.6%3.4%4.8%3.2%2.6%1.7%2.2%
Other income0.03 Cr0.0064 Cr0.41 Cr0 Cr0.21 Cr0.25 Cr0.02 Cr0 Cr0.12 Cr0.02 Cr0.12 Cr0 Cr
Interest0.04 Cr0.11 Cr0.40 Cr0.33 Cr0.03 Cr0.07 Cr0.67 Cr0.70 Cr0.06 Cr0.30 Cr0.79 Cr0.52 Cr
Depreciation0.12 Cr0.12 Cr0.18 Cr0.07 Cr0.07 Cr0.11 Cr0.09 Cr0.10 Cr0.10 Cr0.12 Cr0.11 Cr0.15 Cr
Profit before tax0.51 Cr3 Cr8 Cr3 Cr2 Cr2 Cr4 Cr5 Cr1.00 Cr2 Cr2 Cr2 Cr
Tax %19.9%25.7%29.4%25.6%25.4%26.0%28.6%25.3%25.3%27.2%33.7%25.2%
Net profit0.41 Cr2 Cr6 Cr2 Cr2 Cr1 Cr3 Cr4 Cr0.75 Cr1 Cr1 Cr1 Cr
EPS (₹)₹0.33₹0.20₹0.16₹0.07₹0.04₹0.04₹0.07₹0.09₹0.02₹0.04₹0.03₹0.04

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales246 Cr268 Cr383 CrSign in free for the trailing twelve months
Operating expenses (approx.)229 Cr255 Cr371 CrSign in free for the trailing twelve months
EBITDA17 Cr12 Cr11 CrSign in free for the trailing twelve months
OPM %6.8%4.6%3.0%Sign in free for the trailing twelve months
Other income0.45 Cr0.48 Cr0.26 CrSign in free for the trailing twelve months
Interest1 Cr1 Cr2 CrSign in free for the trailing twelve months
Depreciation0.53 Cr0.35 Cr0.44 CrSign in free for the trailing twelve months
Profit before tax15 Cr11 Cr9 CrSign in free for the trailing twelve months
Tax %27.5%26.7%27.3%Sign in free for the trailing twelve months
Net profit11 Cr8 Cr7 CrSign in free for the trailing twelve months
EPS (₹)₹0.30₹0.22₹0.18Sign in free for the trailing twelve months
Dividend payout %0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital38 Cr38 Cr38 Cr
Reserves24 Cr32 Cr39 Cr
Borrowings19 Cr38 Cr36 Cr
Other liabilities16 Cr23 Cr19 Cr
Total liabilities96 Cr131 Cr131 Cr
Fixed assets (net)2 Cr3 Cr4 Cr
CWIP7 Cr7 Cr7 Cr
Investments0 Cr0.82 Cr0 Cr
Inventories79 Cr111 Cr110 Cr
Trade receivables4 Cr1 Cr2 Cr
Cash & bank0.09 Cr0.03 Cr0.44 Cr
Other assets5 Cr7 Cr8 Cr
Total assets96 Cr131 Cr131 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity32 Cr-16 Cr5 Cr
Cash from investing-6 Cr-1 Cr-2 Cr
Cash from financing-27 Cr18 Cr-3 Cr
Net cash flow0.03 Cr-0.06 Cr0.40 Cr
Free cash flow (OCF − Capex)27 Cr-18 Cr4 Cr

Ratios

MetricMar 2024Mar 2025Mar 2026
ROCE %20.6%11.7%10.0%
ROE %18.4%12.1%9.0%
Debtor days522
Inventory days141243139
Days payable20426
Cash conversion cycle126203135
OCF / EBITDA %195.1%-129.7%n.m.
OCF / EBITDA % (3 years)——53.7%
Debt / equity0.310.540.47
Current ratio2.532.012.25
Net debt / EBITDA1.143.033.13